StocktoriaSensei Biotherapeutics, Inc. FTH
Nasdaq · XNAS · stock · Pharmaceutical Preparations
Chart by TradingView
1/9
Piotroski F — financial health
-37.37
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Operating income | -$22.3M | -$32.6M | -$37.1M | -$50.2M | -$37.5M |
| Net income | -$21.1M | -$30.2M | -$34.1M | -$48.6M | -$36.8M |
| Operating cash flow | -$20.5M | -$24.7M | -$32.0M | -$39.0M | -$30.3M |
| Free cash flow | -$20.5M | -$24.8M | -$32.2M | -$39.3M | -$32.3M |
| Total assets | $22.9M | $45.4M | $74.4M | $118.4M | $153.2M |
| Total liabilities | $4.3M | $7.0M | $9.5M | $15.0M | $6.7M |
| Shareholders' equity | $18.6M | $38.4M | $64.9M | $103.4M | $146.5M |
| Ratios | |||||
| Return on assets | -92.1% | -66.5% | -45.9% | -41.0% | -24.0% |
| Return on equity | -113.4% | -78.6% | -52.5% | -47.0% | -25.1% |
| Current ratio | 5.06 | 7.70 | 11.92 | 11.98 | 30.38 |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 32,041 | $1.0M |
Why these scores methodology →
Piotroski F-score: 1/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -37.37 (distress)
- Working capital / assets 0.753
- Retained earnings / assets -12.363
- EBIT / assets -0.973
- Equity / liabilities 4.314
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001829802 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.